GRO BIOSCIENCES
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders, and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.
GRO BIOSCIENCES
Industry:
Biotechnology Health Diagnostics Medical Device Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.grobio.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 903 8359
Total Funding:
32.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Board_member
Board_member
2019-01-02
Current Employees Featured
Ross Thyer Co-Founder and Advisor @ GRO Biosciences
Co-Founder and Advisor
Justin Feng Principal Scientist @ GRO Biosciences
Principal Scientist
Christopher Gregg Co-Founder and Chief Scientific Officer @ GRO Biosciences
Co-Founder and Chief Scientific Officer
Edward J. Stewart Chief Business Officer @ GRO Biosciences
Chief Business Officer
2021-11-01
Benjamin Stranges Co-Founder and Principal Scientist @ GRO Biosciences
Co-Founder and Principal Scientist
George Church Co-Founder and Advisor @ GRO Biosciences
Co-Founder and Advisor
Daniel J. Mandell Co-Founder and Chief Executive Officer @ GRO Biosciences
Co-Founder and Chief Executive Officer
Marc Lajoie Co-Founder and Advisor @ GRO Biosciences
Co-Founder and Advisor
Andrew Ellington Co-Founder and Advisor @ GRO Biosciences
Co-Founder and Advisor
Founder
Investors List
Alumni Ventures
Alumni Ventures investment in Series A - GRO Biosciences
Digitalis Ventures
Digitalis Ventures investment in Series A - GRO Biosciences
Redmile Group
Redmile Group investment in Series A - GRO Biosciences
Innovation Endeavors
Innovation Endeavors investment in Series A - GRO Biosciences
Leaps by Bayer
Leaps by Bayer investment in Series A - GRO Biosciences
National Science Foundation
National Science Foundation investment in Grant - GRO Biosciences
Innovation Endeavors
Innovation Endeavors investment in Seed Round - GRO Biosciences
Rising Tide
Rising Tide investment in Seed Round - GRO Biosciences
OS Fund
OS Fund investment in Seed Round - GRO Biosciences
Digitalis Ventures
Digitalis Ventures investment in Seed Round - GRO Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-16 | GRO Biosciences Strengthens Management Team With Appointment of Veteran Biotechnology Executive, Edward Stewart as Chief Business Officer |
Official Site Inspections
http://www.grobio.com Semrush global rank: 1.51 M Semrush visits lastest month: 17.75 K
- Host name: 226.11.145.34.bc.googleusercontent.com
- IP address: 34.145.11.226
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Grobio.com lookup results from whois.networksolutions.com server:
- Domain created: 29th-Oct-2015
- Domain updated: 30th-Aug-2024
- Domain expires: 29th-Oct-2025 0 Years, 131 Days left
- Website age: 9 Years, 234 Days
- Registrar Domain ID: 1973278031_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: domain.operations@web.com
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- NS23.WORLDNIC.COM
- NS24.WORLDNIC.COM
More informations about "GRO Biosciences"
GRO Biosciences – Delivering on the Promise of …
Jul 19, 2024 GRObio’s groundbreaking science redefines protein therapeutics with an expanded amino acid alphabet. We have developed the only synthetic biology platform that grants access to the full universe of non-standard amino …See details»
GRO Biosciences - Crunchbase Company Profile
Organization. GRO Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Fierce Biotech — …See details»
George Church spinout restructures, considers strategic options
Mar 13, 2025 GRObio was born out of the George Church Lab at Harvard University in 2016, with the geneticist and serial entrepreneur listed as a co-founder and scientific advisor.See details»
Grobo - Crunchbase Company Profile & Funding
Organization. Grobo . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Grobo uses scientific methods and data-driven …See details»
Careers – GRO Biosciences
GRObio has an inclusive work environment that celebrates diverse perspectives, backgrounds, and approaches to science and business. ... "GRO has been my favorite company to work at …See details»
GRO Biosciences (USA) Funding: $92.3M - medicalstartups.org
Mar 27, 2025 Website: https://www.grobio.com GRO Biosciences is a biotechnology company that expands the amino acid alphabet to overcome the limitations of protein therapeutics. …See details»
GRO Biosciences - BIO CEO & Investor Conference | BIO
Feb 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... GRO …See details»
GRObio - Patrick Wareing
Overview GRO Biosciences (GRObio), a synthetic biology startup spun out of George Church’s lab at Harvard University, is reevaluating its strategy following significant leadership changes …See details»
GRO Biosciences Explores Strategic Alternatives - Patrick Wareing
6 days ago GRObio’s challenges come amid a difficult period for the biotech sector. A downturn in venture capital funding and broader economic uncertainty have forced many companies to …See details»
Synbio startup GRObio gets $25M to work with new building …
Nov 3, 2021 Dan Mandell, GRObio’s co-founder and CEO, was a research fellow in genetics at Harvard, where he worked with Church on computational design of new proteins whose folding …See details»
GRO Platform – GRO Biosciences
GRObio taps into the universe of NSAAs to address pressing unmet clinical needs; New NSAA chemistries will support a portfolio of protein therapeutics that fulfill the promise of precisely …See details»
GRObio Appoints Tracey Lodie, PhD, as Chief Development Officer
Mar 22, 2024 With a proven track record in immunology and biopharmaceutical development, Dr. Lodie’s expertise is poised to accelerate GRObio’s journey from research to real-world …See details»
GRObio Secures $60.3 Million in Series B Financing to Advance …
GRO Biosciences (), a biotechnology company pioneering the expansion of the amino acid alphabet through synthetic biology, has announced the successful closure of a $60.3 million …See details»
GRO Biosciences: New amino acids for better biologics could …
Mar 5, 2024 GRObio is using its innovative platform and NSAAs to transform treatments in diverse areas, such as autoimmune and metabolic diseases. The company is now advancing …See details»
GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas …
Find GRObio on LinkedIn, Twitter, Instagram, Facebook and the web at grobio.com. About Atlas Venture Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by …See details»
GRO gathers $60M series B to take gout therapy into clinic - Fierce …
Jul 19, 2024 The new funding will be used to take ProGly-Uricase into a phase 1 trial of patients with elevated uric acid levels, as well as to “broaden the GRObio pipeline, and to expand its …See details»
GRO Biosciences Expands Executive Team with Appointment of …
BOSTON, March 18, 2024 – GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the …See details»
Cuts and shake-up as GRObio reviews strategy
Mar 21, 2025 GROBio added it is assessing: “multiple options for the development and advancement of its platform and intellectual property,” but declined to comment further. This …See details»
GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas …
BOSTON, July 19, 2024 – GRO Biosciences Inc. (“GRObio”), a biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of …See details»
GroBio.io Overview | SignalHire Company Profile
At GroBio, we empower life sciences companies to transcend borders, elevate their commercial strategies, and embrace the digital age. ... Organization Website: grobio.io : GroBio.io …See details»